Dexmedetomidine Combined With Bupivacaine in Ultrasound-guided Pecto-Intercostal Fascial Block in Cardiac Surgery
Launched by ALEXANDRIA UNIVERSITY · Jun 14, 2025
Trial Information
Current as of June 26, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at a new way to help manage pain after heart surgery. It focuses on a technique called the pecto-intercostal fascial plane block (PIFPB), where a local numbing medicine is carefully placed near certain chest muscles using ultrasound guidance. This helps numb the nerves that carry pain signals from the chest area, especially around the breastbone. The study is testing whether adding a medicine called dexmedetomidine can make the pain relief stronger and last longer after surgery.
Adults aged 18 to 60 who are scheduled for planned heart surgery using a heart-lung machine may be able to join this study. To participate, patients should be in generally stable health (classified as ASA II or III) and not have serious liver, kidney, or heart failure problems. People with allergies to the study medicines, those who have had previous chest surgeries, or those who use long-term pain medications would not be eligible. If you take part, you can expect to receive the nerve block during your surgery to help control pain afterward, with the goal of making recovery more comfortable and possibly speeding up your healing process.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. Age 18-60 years.
- • 2. Both sexes.
- • 3. ASA physical status class II or III.
- • 4. Elective fast-tracking on-pump cardiac surgery.
- Exclusion Criteria:
- • 1. The patient refused to participate in the study.
- • 2. Cognitive impairment or mental disorders.
- • 3. Hepatic and renal impairment.
- • 4. Congestive heart failure.
- • 5. Urgent/emergent surgery.
- • 6. BMI \<18 and \>35 (kg/m2).
- • 7. Documented allergy to local anaesthetics or dexmedetomidine.
- • 8. Use of chronic pain medications.
- • 9. Previous sternotomy or chest surgery.
- • 10. Patients with a history of substance abuse.
- • 11. Requires the use of mechanical circulatory support pre-operatively.
- • 12. Patients who will not be candidates for fast-tracking extubation after block administration.
About Alexandria University
Alexandria University, a leading academic institution in Egypt, is dedicated to advancing medical research and improving healthcare outcomes through innovative clinical trials. With a strong emphasis on collaboration and interdisciplinary approaches, the university leverages its extensive resources and expertise to conduct rigorous studies that address pressing health challenges. By fostering partnerships with healthcare professionals, industry leaders, and regulatory bodies, Alexandria University aims to contribute to the global body of medical knowledge and enhance the quality of patient care through evidence-based findings.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Trial Officials
LECTURER OF ANESTHESIA AND SURGICAL INTENSIVE CARE
Principal Investigator
University of Alexandria
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported